Skip to main content
. 2017 Jul 25;61(8):e00629-17. doi: 10.1128/AAC.00629-17

FIG 3.

FIG 3

ClfA-alpha-toxin bispecific antibodies compared to IgG1. (A) Bispecific constructs using anti-ClfA MAb as a scaffold. scFv of anti-alpha-toxin MAb MEDI4893* were linked via a 10-amino-acid linker (GGGGx2) to the ClfA MAb heavy-chain N terminus (B) or heavy-chain C terminus (C).